| BCBS Federal Medical & Drug | 5.21.099 Vyxeos (daunorubicin and cytarabine) | 2026-03-06 |
| BCBS Federal Medical & Drug | 5.21.100 Besponsa (inotuzumab ozogamicin) | 2026-03-06 |
| BCBS Federal Medical & Drug | 5.21.101 Kymriah (tisagenlecleucel) | 2026-03-06 |
| BCBS Federal Medical & Drug | 5.21.102 Mylotarg (gemtuzumab ozogamicin) | 2026-03-06 |
| BCBS Federal Medical & Drug | 5.21.103 Aliqopa (copanlisib) | 2026-03-06 |
| BCBS Federal Medical & Drug | 5.21.104 Verzenio (abemaciclib) | 2026-03-06 |
| BCBS Federal Medical & Drug | 5.21.105 Yescarta (axicabtagene ciloleucel) | 2026-03-06 |
| BCBS Federal Medical & Drug | 5.21.106 Calquence (acalabrutinib) | 2026-03-06 |
| BCBS Federal Medical & Drug | 5.21.108 Erleada (apalutamide) | 2026-03-06 |
| BCBS Federal Medical & Drug | 5.21.110 Braftovi (encorafenib) | 2026-03-06 |